SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

Reports that Anthropic may be IRENs previously undisclosed AI customer sparked intense discussion, but the partnership remains unconfirmed. Traders debate whether the speculation supports a lasting re-rating or a sell-the-news move, while broader concerns about infrastructure execution, financing and recent weakness temper the bullish reaction.

W.F Holding Ltd. engages in the manufacture of fiberglass reinforced plastic and FRP products. It sells a range of FRP products, including filament wound and molded tanks, thermoplastic tanks, lining products, ducting and fitting products, air pollution control equipment, and custom-made products. The firm also offer delivery, installation and repair, maintenance services, and on-site consultation services. The company was founded on March 7, 2023 and is headquartered in Shah Alam, Malaysia.

WF Holding Ltd.

WF Holding Limited Ordinary Shares

WFFs sharp, highly volatile surge is drawing attention as a speculative momentum trade, with traders variously attributing the move to algorithmic buying, FOMO, or possible short covering rather than a confirmed company catalyst. Bulls are betting on more upside, while bears warn that the run lacks clear fundamental support and could reverse sharply, citing dilution risk and the companys weak financial position.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs rally to fresh highs is drawing attention, with traders pointing to recent analyst upgrades and optimism about AI and sovereign-AI demand ahead of earnings. Bulls are celebrating the breakout and speculating about short covering, while skeptics argue the valuation is stretched and warn of a pullback.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention for its prolonged selloff toward 52-week lows despite analyst upgrades and defense-contract wins across drones, hypersonics, space and cyber. Bulls are buying the dip on long-term defense demand and backlog growth, while skeptics cite persistent selling, insider sales, valuation and cash-flow concerns, questioning whether contract momentum will translate into profitable growth.

ETF Opportunities Trust - T-REX 2X Long GME Daily Target ETF

T-REX 2X Long GME Daily Target ETF

GMEU is attracting attention as a leveraged play on GameStops rebound, with bullish traders highlighting its gains and speculating about a short squeeze and tight share borrowing. Others caution that daily leverage and volatility can cause it to lag GME over time, and prefer owning the underlying shares.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

RIOT is drawing attention amid a sharp, volatile pullback, with traders pointing to Bitcoin-miner weakness and disappointment that its AI/data-center dealsincluding the Anthropic leasehave not supported the share price. Bulls see the pivot and a potential Corsicana tenant as future catalysts, while skeptics question whether the AI contracts can offset the stocks Bitcoin exposure and are watching for further technical support.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Speculation that Johnson & Johnson could acquire Sellas Life Sciences is a major focus, with traders pointing to perceived executive connections and J&Js oncology ambitions; no deal is confirmed. Others are watching J&Js upcoming quarterly results and debating the stocks recent strength.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys rally is drawing attention amid optimism that AI-powered, agentic shopping could expand its commerce business, including through Metas Muse integration and bullish analyst commentary. Traders are celebrating the breakout and strong momentum, while others warn the run may be stretched and flag resistance and possible pullbacks.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

RETIRE is drawing attention from a community push around its on-chain 401(k) and early-retirement meme-coin narrative, with supporters promoting recurring DCA and celebrating recent momentum. Skeptics counter that it is a highly speculative pump-and-dump, while holders debate selling pressure and whether the gains can hold.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillows earnings and lowered residential outlook are fueling debate against a weak housing backdrop, with traders pointing to high mortgage rates and muted home-buying activity. Some view the selloff as overdone and the stock as undervalued, while others expect continued pressure as housing demand remains subdued.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VKTXs sharp selloff after its secondary offering and Chief Commercial Officer Neil Aubuchons departure dominates discussion, with traders debating whether dilution, management uncertainty and a long wait for further clinical catalysts have weakened the near-term outlook. Bulls remain focused on VK2735s encouraging data and advancing oral and injectable programs, while buyout and partnership talk remains speculative.

Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?

Key PointsViking Therapeutics will soon enter phase 3 trials with its weight loss pill candidate...

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $28.53, representing a +2.88% change from its previous close.

Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $27.73, denoting a -2.84% move from the preceding trading day.

LLY Stock Down 2% in 3 Months: Is the Dip a Buying Opportunity?

LLY's recent dip reflects valuation and competition concerns, but strong GLP-1 demand, pipeline growth and diversification support its long-term outlook.

VKTX Advances Obesity Program With New Oral Maintenance Study

VK2735's oral maintenance study could expand Viking Therapeutics' obesity strategy by helping sustain weight loss with less frequent dosing.

INSM Stock Slides on CFO Exit, Reiterates '26 Sales View

Insmed shares slide after CFO Sara Bonstein's surprise exit, though the company reaffirms 2026 revenue guidance for Brinsupri and Arikayce.

VKTX Down 16% in a Month: Time to Invest or Exit the Stock?

Viking Therapeutics faces dilution and rising obesity competition, but VK2735's pipeline progress could offer catalysts and support a rebound.

Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with ObesityPR NewswireSAN DIEGO, Oct. 6, 2026Study to Explore Oral Maintenance...

LLY Highlights New Efficacy Data From Foundayo and EloraTZP Studies

Eli Lilly's new data show Foundayo's cardiovascular safety and metabolic benefits, while EloraTZP delivers greater weight loss and A1C reduction in a mid-stage study.

Viking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors

Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $30.51, moving 6.41% from the previous trading session.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Dow, S&P 500, Nasdaq Futures Fall Amid Rising Bond Yields, AI Concerns: KOD, SMMT, CLF, VKTX Stocks In Focus

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are actively debating the timing and likelihood of a potential acquisition by Big Pharma, with some speculating that a major deal could be imminent.

Discussions center on the execution of the oral Phase 3 SUNRISE trials and the advancement of best-in-class assets, despite recent stock volatility.

Retail investors are expressing frustration over the recent departure of the CCO and questioning CEO compensation structures and corporate transparency.

Traders are closely monitoring massive short interest data and technical support levels while preparing for potential squeezes driven by positive clinical data.

Current Price	$28.51
Prev Close	$27.73
Open	$27.85
Dividend Yield	0.00%
50-Day Moving Average	$32.79
Beta	1.65
Avg. Volume	7.34M
PE Ratio	-6.12

52-Week High	$43.15
52-Week Low	$25.77
Market Capitalization	$3.63B
EPS (Annual)	-$3.19
Price to Book	8.15
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

VKTX Fundamentals